LEMAITRE VASCULAR INC - Common Stock (LMAT)

Q1 2021 13F Holders as of 3/31/2021

Type / Class
Equity / Common Stock
Shares outstanding
22.5M
Number of holders
178
Total 13F shares, excl. options
17.9M
Shares change
+352K
Total reported value, excl. options
$876M
Value change
+$18.3M
Number of buys
80
Number of sells
-78
Price
$48.78

Significant Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q1 2021

195 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock as of Q1 2021.
LEMAITRE VASCULAR INC - Common Stock (LMAT) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.9M shares of 22.5M outstanding shares and own 79.76% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.08M shares), Conestoga Capital Advisors, LLC (1.9M shares), VANGUARD GROUP INC (1.11M shares), GENEVA CAPITAL MANAGEMENT LLC (920K shares), Copeland Capital Management, LLC (891K shares), DIMENSIONAL FUND ADVISORS LP (700K shares), STATE STREET CORP (679K shares), Ranger Investment Management, L.P. (503K shares), Summit Creek Advisors LLC (446K shares), and KENNEDY CAPITAL MANAGEMENT, INC. (445K shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.